In this study, we evaluated the gastric protective activities of mokdanpi in vitro. Further, we used experimental ulcer models to identify the active ingredients of mokdanpi. As a preliminary evaluation of mokdanpi ethanolic extract and its ingredients, we assessed its radical scavenging activities. In addition, its antimicrobial activity against Helicobacter pylori (H. pylori) was investigated. The antiulcerogenic activity of the active ingredients was evaluated in pylorus-ligated rats, an HCl/ethanol-induced and an absolute ethanol-induced ulcer model. We confirmed the scavenging effect of the ethanolic extract of mokdanpi and its ingredients against 2,2-diphenyl-1-picrylhydrazyl, nitric oxide and superoxide radicals, and we demonstrated that mokdanpi could inhibit the colonization of H. pylori. In an HCl-ethanol-induced ulcer model, gallic acid and catechin (100 mg/kg) inhibited 40.6% and 41.7% of gastric lesions, respectively. Catechin (100 mg/kg) significantly reduced (p<0.05) the gastric secretion induced by pylorus ligature in rats in comparison to the control group. Gallic acid (100 mg/kg) significantly increased (p<0.05) the mucus contents in an ethanol-induced ulcer model. The antioxidant ingredients (catechin and gallic acid) present in mokdanpi play a major role in antiulcerogenic activity, and demonstrate novel activity against H. pylori.
Key words Paeonia suffruticosa; Helicobactor pylori; gastric ulcer; gastric cancer; catechin; gallic acidA large portion of the world's population is afflicted with gastric diseases, such as gastric ulcer, gastritis, and gastric cancer. These diseases are induced by stress, smoking, infection by Helicobacter pylori (H. pylori), and nutritional deficiencies.1) Gastric ulcers result from an imbalance between aggressive factors (i.e., gastric acid, pepsin, stimulation of the vagus nerves, secretion of gastrin, and an increased number of parietal cells) and protective factors (i.e., bicarbonate ion, mucus productivity, mucus secretion, and prostaglandins).
2)In particular, frequent gastritis or gastric ulcer is chronic and leads to death. Another important risk factor is infection from H. pylori. Since reports indicate that H. pylori-induced gastritis leads to gastric cancer, the control of H. pylori in the stomach has become a target of treatment for gastric diseases. The antibodies for H. pylori are higher in patients with gastric cancer than in control groups.3) For eradication of H. pylori, a combination therapy with a proton pump inhibitor (PPI) or bismuth and antibiotics has been used. Nevertheless, the infection rate remains high and new therapeutic alternatives are needed because of antimicrobial resistance. In this regard, plant-derived extracts have been considered in the development of antiulcerogenic drugs.Mokdanpi, the root cortex of Paeonia suffruticosa ANDREWS (Panunculaceae), is an important crude drug with analgesic, sedative, and anti-inflammatory activities, and has been used as a remedy for cardiovascular extravasated blood and female genital diseas...